Skip to main content

You are here

The pharmaceutical industry in Belgium continues to grow

In 2016, Belgium’s pharmaceutical industry posted excellent growth figures in terms of exports, R&D investments and job creation. This is confirmed by pharma.be – the general pharmaceuticals association – in its annual report.

Innovative R&D hub

“Belgian universities and research centers work closely together. Not only does this create a stimulating environment for innovation, it also translates into major R&D investment figures in the pharmaceutical sector,” comments Catherine Rutten, CEO at pharma.be.

Last year, pharma players channeled no less than EUR 2.89 billion in R&D – reaffirming that the pharmaceutical industry is Belgium’s most innovative sector. What’s more, this figure is not only up 11.6% over the year before, but also sets a new record.

The number of highly qualified researchers in the sector also continues to go up. Last year, 4,500 Belgians employed in the pharmaceutical industry are active in research activities. This represents an increase of 5.5% compared to 2015.

€ 2.9 bln
R&D expenditure in 2016

World champion in exports

Pharmaceuticals are also a driving force behind Belgium’s economy, representing more than a tenth of its total exports. In 2016, the sector exported EUR 40.7 billion in medicines and vaccines, nearly reaching 2015’s record value of EUR 41.01 billion.

“Our unique location in Europe, easy access to international markets and excellent infrastructure for the distribution of pharmaceuticals are the main reasons for this success,” Rutten points out.

Some remarkable facts and figures about Belgium’s pharma exports:

  • nearly half of the exports (47.6%) is outbound to countries outside the EU;
  • around a fifth (20.6%) is destined for North American markets; and
  • approximately one-eighth (12.6%) goes to markets in Asia.

Major employer

“In addition to top-notch infrastructure, pharma companies of all sizes have access to a broad pool of highly-educated talent in Belgium,” Rutten concludes. “This facilitates not only the research and development process, but also the production and export of innovative pharmaceutical products.”

The talent pool is only getting bigger in Belgium. In 2016, the local pharma industry employed no fewer than 35,250 people, creating 552 additional jobs (an increase of 1.6% compared to 2015). 

More than half (57.7%) completed higher education studies, and nearly one in three (29%) attended university

About Belgium and Flanders

With Dutch as its official language, Flanders (Dutch: Vlaanderen) is the northern region of Belgium. The capital of both Belgium and Flanders is Brussels.

25 April 2017

Looking for a supplier or business partner?

Contact us now

Why contact us?

  • Tailor-made advice
  • Extensive network of experts
  • Office near you
  • 100% confidential
  • Free of charge

Discover companies from Flanders

Flemish companies are present at events worldwide. These events showcase the excellence of companies from Flanders.

Looking for a company in a specific sector?

> Check our events and its participants

About us

Flanders Investment & Trade is the government agency which promotes sustainable international business, in the interest of both your company and the Flanders-based enterprises.

Flanders is the northern federated state of Belgium with Brussels as its capital. Flanders is the gateway to Europe. The region boasts a wide range of creative companies that offer the products and services you need.

The pharmaceutical industry in Belgium continues to grow | Source From Flanders

Error

Error message

  • Migration FitSourceContactPersons could not be constructed.
  • sFTP login failed
The website encountered an unexpected error. Please try again later.